Saliva versus Upper Respiratory Swabs
- 27 April 2022
- journal article
- research article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 24 (7), 727-737
- https://doi.org/10.1016/j.jmoldx.2022.03.012
Abstract
No abstract availableKeywords
Funding Information
- NIH
- University of Pennsylvania
This publication has 47 references indexed in Scilit:
- Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2Journal of Clinical Microbiology, 2020
- Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2Clinical Infectious Diseases, 2020
- Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Clinical Infectious Diseases, 2020
- A minimal common outcome measure set for COVID-19 clinical researchThe Lancet Infectious Diseases, 2020
- Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional studyClinical Microbiology & Infection, 2020
- Saliva is a reliable tool to detect SARS-CoV-2Journal of Infection, 2020
- Consistent Detection of 2019 Novel Coronavirus in SalivaClinical Infectious Diseases, 2020
- Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2Emerging Microbes & Infections, 2020
- Methods and recommendations for evaluating and reporting a new diagnostic testEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012